Comparison of three feline leukaemia virus (FeLV) point-of-care antigen test kits using blood and saliva

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 50, Issue , 2017, Pages 88-96

  Westman, Mark E ^a   Malik, Richard ^a   Hall, Evelyn ^a   Sheehy, Paul A ^a   Norris, Jacqueline M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antigen testing; Cats; Feline leukaemia virus; FeLV diagnosis; PCR; Saliva; Whole blood

Indexed keywords

ANTIGEN DETECTION; ARTICLE; AUSTRALIA; BLOOD CULTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FELINE LEUKEMIA; FELINE LEUKEMIA VIRUS; FEMALE; INTERMETHOD COMPARISON; MALE; NONHUMAN; POINT OF CARE TESTING; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; ANIMAL; CAT; CAT DISEASES; COMPARATIVE STUDY; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; GERMFREE ANIMAL; IMMUNOLOGY; ISOLATION AND PURIFICATION; RETROVIRIDAE INFECTIONS; SALIVA; TUMOR VIRUS INFECTIONS; VETERINARY; VIROLOGY;

DIAGNOSTIC KIT; VIRUS ANTIGEN;

ANIMALS; ANTIGENS, VIRAL; AUSTRALIA; CAT DISEASES; CATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNODEFICIENCY VIRUS, FELINE; LEUKEMIA VIRUS, FELINE; POINT-OF-CARE TESTING; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; SALIVA; SENSITIVITY AND SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR VIRUS INFECTIONS;

EID: 85007417068     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2016.11.014     Document Type: Article

References (41)

1. [1] Jarrett, W.F.H., Crawford, E.M., Martin, W.B., Davie, F., Leukaemia in the cat: a virus-like particle associated with leukaemia (lymphosarcoma). Nature 202:4932 (1964), 567–568.
2. [2] Hartmann, K., Clinical aspects of feline retroviruses: a review. Viruses 4:11 (2012), 2684–2710.
3. [3] Lutz, H., Addie, D., Belák, S., Boucraut-Baralon, C., Egberink, H., Frymus, T., Gruffydd-Jones, T., Hartmann, K., Hosie, M.J., Lloret, A., Marsilio, F., Pennisi, M.G., Radford, A.D., Thiry, E., Truyen, U., Horzinek, M.C., Feline leukaemia ABCD guidelines on prevention and management. J. Feline Med. Surg. 11:7 (2009), 565–574.
4. [4] Englert, T., Lutz, H., Sauter-Louis, C., Hartmann, K., Survey of the feline leukemia virus infection status of cats in Southern Germany. J. Feline Med. Surg. 14:6 (2012), 392–398.
5. [5] Lopez, N.A., Jacobson, R.H., Scarlett, J.M., Center, S.A., Randolph, J.F., Scott, F.W., Sensitivity and specificity of blood test kits for feline leukemia virus antigen. J. Am. Vet. Med. Assoc. 195:6 (1989), 747–751.
6. [6] Hawks, D.M., Legendre, A.M., Rohrbach, B.W., Comparison of 4 test kits for feline leukemia virus antigen. J. Am. Vet. Med. Assoc. 199:10 (1991), 1373–1377.
7. [7] Hartmann, K., Werner, R.M., Egberink, H., Jarrett, O., Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections. Vet. Rec. 149:11 (2001), 317–320.
8. [8] Robinson, A., DeCann, K., Aitken, E., Gruffydd-Jones, T.J., Sparkes, A.H., Werret, G., Harbour, D.A., Comparison of a rapid immunomigration test and ELISA for FIV antibody and FeLV antigen testing in cats. Vet. Rec. 142:18 (1998), 491–492.
9. [9] Hartmann, K., Griessmayr, P., Schulz, B., Greene, C.E., Vidyashankar, A.N., Jarrett, O., Egberink, H.F., Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection. J. Feline Med. Surg. 9:6 (2007), 439–445.
10. [10] Sand, C., Englert, T., Egberink, H., Lutz, H., Hartmann, K., Evaluation of a new in-clinic test system to detect feline immunodeficiency virus and feline leukemia virus infection. Vet. Clin. Pathol. 39:2 (2010), 210–214.
11. [11] Francis, D.P., Essex, M., Hardy, W.D., Excretion of feline leukemia virus by naturally infected pet cats. Nature 269:5625 (1977), 252–254.
12. [12] Lutz, H., Jarrett, O., Detection of feline leukemia virus infection in saliva. J. Clin. Microbiol. 25:5 (1987), 827–831.
13. [13] Gomes-Keller, M.A., Gonczi, E., Tandon, R., Riondato, F., Hofmann-Lehmann, R., Meli, M.L., Lutz, H., Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. J. Clin. Microbiol. 44:3 (2006), 916–922.
14. [14] Lewis, M.G., Wright, K.A., Lafrado, L.J., Shanker, P.J., Palumbo, N.E., Lemoine, E.D., Olsen, R.G., Saliva as a source of feline leukemia virus antigen for diagnosis of disease. J. Clin. Microbiol. 25:7 (1987), 1320–1322.
15. [15] Lopez, N.A., Scarlett, J.M., Pollock, R.V.H., Jacobson, R.H., Sensitivity, specificity and predictive values of Clinease-virastat saliva test for feline leukemia virus infection. Cornell Vet. 80:1 (1990), 75–84.
16. [16] Levy, J., Crawford, K., Hofmann-Lehmann, S., Sundahl, E., Thayer, V., American Association of Feline Practitioners’ feline retrovirus management guidelines. J. Feline Med. Surg. 10:3 (2008), 300–316 2008.
17. [17] Westman, M.E., Malik, R., Hall, E., Sheehy, P.A., Norris, J.M., Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits. Comp. Immun. Microbiol. Infect. Dis. 42 (2015), 43–52.
18. [18] Westman, M.E., Malik, R., Hall, E., Norris, J.M., The protective rate of the feline immunodeficiency virus vaccine: an Australian field study. Vaccine 34 (2016), 4752–4758.
19. [19] Tandon, R., Cattori, V., Gomes-Keller, M.A., Meli, M.L., Golder, M.C., Lutz, H., Hofmann-Lehmann, R., Quantitation of feline leukaemia virus viral and proviral loads by TaqMan (R) real-time polymerase chain reaction. J. Virol. Methods 130:1-2 (2005), 124–132.
20. [20] Helps, C.R., Lait, P., Damhuis, A., Bjornehammar, U., Bolta, D., Brovida, C., Chabanne, L., Egberink, H., Ferrand, G., Fontbonne, A., Pennisi, M.G., Gruffydd-Jones, I., Gunn-Moore, D., Hartmann, K., Lutz, H., Malandain, E., Mostl, K., Stengel, C., Harbour, D.A., Graat, E.A.M., Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet. Rec. 156:21 (2005), 669–673.
21. [21] Pinches, M.D.G., Helps, C.R., Gruffydd-Jones, T.J., Egan, K., Jarrett, O., Tasker, S., Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction. J. Feline Med. Surg. 9:1 (2007), 8–13.
22. [22] https://www.idexx.com/resource-library/smallanimal/snap-combo-package-insert-en.pdf.
23. [23] Westman, M.E., Malik, R., Hall, E., Norris, J.M., Diagnosing feline immunodeficiency virus (FIV) infection in FIV-vaccinated and FIV-unvaccinated cats using saliva. Comp. Immun. Microbiol. Infect. Dis. 46 (2016), 66–72.
24. [24] Shelton, G.H., Grant, C.K., Cotter, S.M., Gardner, M.B., Hardy, W.D. Jr., DiGiacomo, R.F., Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968–1988). J. Acquir. Immune. Defic Syndr. 3:6 (1990), 623–630.
25. [25] Gleich, S., Hartmann, K., Hematology and serum biochemistry of feline immunodeficiency virus infected and feline leukemia virus infected cats. J. Vet. Intern. Med. 23:3 (2009), 552–558.
26. [26] Beatty, J.A., Tasker, S., Jarrett, O., Lam, A., Gibson, S., Noe-Nordberg, A., Phillips, A., Fawcett, A., Barrs, V.R., Markers of feline leukaemia virus infection or exposure in cats from a region of low seroprevalence. J. Feline Med. Surg. 13:12 (2011), 927–933.
27. [27] Möstl, K., Egberink, H., Addie, D., Frymus, T., Boucraut-Baralon, C., Truyen, U., Hartmann, K., Lutz, H., Gruffydd-Jones, T., Radford, A.D., Lloret, A., Pennisi, M.G., Hosie, M.J., Marsilio, F., Thiry, E., Belák, S., Horzinek, M.C., Prevention of infectious diseases in cat shelters: ABCD guidelines. J. Feline Med. Surg. 15:7 (2013), 546–554.
28. [28] Hawkins, E.C., Saliva and tear tests for feline leukemia virus. J. Am. Vet. Med. Assoc. 199:10 (1991), 1382–1385.
29. [29] Westman, M.E., Paul, A., Malik, R., McDonagh, P., Ward, M.P., Hall, E., Norris, J.M., Seroprevalence of feline immunodeficiency virus and feline leukaemia virus in Australia: risk factors for infection and geographical influences (2011–2013). J. Feline Med. Surg. Open Rep., 2016, 2.
30. [30] Lopez, N.A., Jacobson, R.H., False-positive reactions associated with anti-mouse activity in serotests for feline leukemia virus antigen. J. Am. Vet. Med. Assoc. 195:6 (1989), 741–746.
31. [31] Buch, J.S., Clark, G.H., Cahill, R., Thatcher, B., Smith, P., Chandrashekar, R., Leutenegger, C.M., O'Connor, T.P., Beall, M.J., Validation of reference laboratory FeLV p27 antigen ELISA. J. Vet. Diagn. Invest., 2016 (in press).
32. [32] Barr, M.C., FIV, FeLV, and FIPV: interpretation and misinterpretation of serological test results. Seminars in Veterinary Medicine and Surgery. Small Anim. 11:3 (1996), 144–153.
33. [33] Willett, B.J., Hosie, M.J., Feline leukaemia virus: half a century since its discovery. Vet. J. 195:1 (2013), 16–23.
34. [34] Rojko, J.L., Hoover, E.A., Quackenbush, S.L., Olsen, R.G., Reactivation of latent feline leukaemia virus infection. Nature 298:5872 (1982), 385–388.
35. [35] Gabor, L.J., Jackson, M.L., Trask, B., Malik, R., Canfield, P.J., Feline leukaemia virus status of Australian cats with lymphosarcoma. Aust. Vet. J. 79:7 (2001), 476–481.
36. [36] Jackson, M.L., Haines, D.M., Meric, S.M., Misra, V., Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma. Can. J. Vet. Res. 57:4 (1993), 269–276.
37. [37] Nesina, S., Helfer-Hungerbuehler, A.K., Riond, B., Boretti, F.S., Willi, B., Meli, M.L., Grest, P., Hofmann-Lehmann, R., Retroviral DNA − the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naive recipient cats. Retrovirology, 12(105), 2015 (21 December 2015)-(21 December 2015).
38. [38] Hofmann-Lehmann, R., Huder, J.B., Gruber, S., Boretti, F., Sigrist, B., Lutz, H., Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J. Gen. Virol. 82 (2001), 1589–1596.
39. [39] Crawford, P.C., Levy, J.K., New challenges for the diagnosis of feline immunodeficiency virus infection. Vet. Clin. North Am. Small Anim. Pract. 37:2 (2007), 335–350.
40. [40] Miyazawa, T., Jarrett, O., Feline leukaemia virus proviral DNA detected by polymerase chain reaction in antigenaemic but non-viraemic ('discordant') cats. Arch. Virol. 142:2 (1997), 323–332.
41. [41] Helfer-Hungerbuehler, A.K., Widmer, S., Kessler, Y., Riond, B., Boretti, F.S., Grest, P., Lutz, H., Hofmann-Lehmann, R., Long-term follow up of feline leukemia virus infection and characterization of viral RNA loads using molecular methods in tissues of cats with different infection outcomes. Virus Res. 197 (2015), 137–150.